INS and diabetes mellitus: Even in the absence of overt diabetes, TS patients often exhibit various disruptions in glucose metabolism, such as hyperinsulinemia, insulin resistance, decreased insulin secretion, and impaired glucose tolerance [88,89] These disturbances likely reflect a combination of impaired early-phase insulin release and reduced β-cell responsiveness.